Cargando…
Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
Fumarate hydratase (FH)-deficient kidney cancer undergoes metabolic remodeling, with changes in mitochondrial respiration, glucose, and glutamine metabolism. These changes represent multiple biochemical adaptations in glucose and fatty acid metabolism that supports malignant proliferation. However,...
Autores principales: | Yang, Youfeng, Lane, Andrew N., Ricketts, Christopher J., Sourbier, Carole, Wei, Ming-Hui, Shuch, Brian, Pike, Lisa, Wu, Min, Rouault, Tracey A., Boros, Laszlo G., Fan, Teresa W.-M., Linehan, W. Marston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744468/ https://www.ncbi.nlm.nih.gov/pubmed/23967283 http://dx.doi.org/10.1371/journal.pone.0072179 |
Ejemplares similares
-
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc
por: Sourbier, Carole, et al.
Publicado: (2019) -
Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
por: Kerins, Michael J., et al.
Publicado: (2018) -
Hereditary leiomyomatosis and renal cell carcinoma
por: Schmidt, Laura S, et al.
Publicado: (2014) -
Cutaneous and uterine leiomyomatosis and ovarian cystadenoma associated with deficiency of fumarate hydratase
por: Hüller, Cornelia, et al.
Publicado: (2011) -
HIF and fumarate hydratase in renal cancer
por: Sudarshan, S, et al.
Publicado: (2007)